VIDEO & ARTICLE Bexarotene is an FDA-approved anti-cancer drug available under the brand name Targretin®. It clears Alzheimer’s biomarkers in mice like a charm. See
50,000 volunteers (with and without Alzheimer’s) are needed to participate in hundreds of clinical trials. People with Alzheimer’s, their families, and those who serve them
In 2012, Envivo’s experimental Alzheimer’s drugs improved cognitive function as the company won a Fierce BioTech Award. Learn about and participate in their newest Phase-2
Merck announced it is enrolling volunteers for the EPOCH clinical trial. Read details on their highly promising MK-8931 treatment for mild-to-moderate Alzheimer’s disease. Find out
VIDEO & ARTICLE Solanezumab slowed Alzheimer’s by 30% in a trial earlier this year. Find out what it’s maker, Ely Lilly, plans for the next step.
VIDEO & ARTICLE In trials, the most effective Alzheimer’s treatment so far is IVIG. At $50,000 per year, learn how scientists hope to bring down
VIDEO Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’
MARIJUANA VIDEO – Dr. Gregger:
Vascular dementia often results from strokes. In a huge study of 2 million pot smokers, hospitalization from ischemic stroke increased 17%. See more about this vascular-dementia-marijuana connection.
MAUDE’S AWARDS RECOGNIZE AND REWARD INNOVATIVE CARE
FOR PERSONS LIVING WITH ALZHEIMER’S DISEASE. AWARD APPLICATIONS OPEN NOW!
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
